Long Bridge Medical Receives Clearance from FDA to Initiate the U.S. Pivotal Clinical Study for LensOne Prosthetic Capsular Bag

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Long Bridge Medical, Inc. today announced that the U.S. Food and Drug Administration (FDA) has cleared initiation of its Investigational Device Exemption (IDE) study for LensOne™, the company's prosthetic capsular bag designed to enable reliable secondary intraocular lens (IOL) fixation in patients with absent or compromised lens capsule support in poor candidates for anterior chamber intraocular lenses (ACIOL). The approval of the IDE application e